BioCentury
ARTICLE | Clinical News

Enzon, Santaris preclinical data

December 6, 2010 8:00 AM UTC

In mouse xenograft models of colon and lung cancer, EZN-3892 significantly inhibited tumor growth by 71% and 76%, respectively, vs. saline-treated controls. The beta-catenin (CTNNB1) RNA antagonist w...